Extranodal involvement of non-Hodgkin lymphoma (NHL) has been reported in 20–40% of patients and has been typically observed in the skin, bones, gastrointestinal tract, liver and brain. Cardiac involvement has been reported in up to 20% of autopsy cases of patients with NHL and accounts for about 2% of all cardiac malignancies. Here, we report a peculiar case of a secondary cardiac diffuse large B-cell lymphoma (DLBCL), occurring with an abrupt hemodynamic instability, characterized by a sudden ventricular tachycardia and cardiogenic shock. The patient promptly started the first cycle of chemotherapy and was admitted to the cardiac intensive care unit (CICU) of our institution to prevent potential cardiovascular complications during treatment. We applied a fractionated treatment approach, progressively reaching standard doses, to decrease the risk of early death and ensure a successful management.
Arrhythmias and cardiogenic shock: a rare disease presentation of diffuse large B-cell lymphoma with cardiac involvement / Mariani, Sabrina; Pelliccia, Sabrina; Bianchi, MARIA PAOLA; Piedimonte, Monica; Bongiovanni, Martina; Testa, Marco; DI NAPOLI, Arianna; Tafuri, Agostino. - In: HEMATO. - ISSN 2673-6357. - 2:2(2021), pp. 353-357. [10.3390/hemato2020021]
Arrhythmias and cardiogenic shock: a rare disease presentation of diffuse large B-cell lymphoma with cardiac involvement
Sabrina Mariani;Sabrina Pelliccia;Maria Paola Bianchi;Monica Piedimonte;Martina Bongiovanni;Marco Testa;Arianna Di Napoli;Agostino Tafuri
2021
Abstract
Extranodal involvement of non-Hodgkin lymphoma (NHL) has been reported in 20–40% of patients and has been typically observed in the skin, bones, gastrointestinal tract, liver and brain. Cardiac involvement has been reported in up to 20% of autopsy cases of patients with NHL and accounts for about 2% of all cardiac malignancies. Here, we report a peculiar case of a secondary cardiac diffuse large B-cell lymphoma (DLBCL), occurring with an abrupt hemodynamic instability, characterized by a sudden ventricular tachycardia and cardiogenic shock. The patient promptly started the first cycle of chemotherapy and was admitted to the cardiac intensive care unit (CICU) of our institution to prevent potential cardiovascular complications during treatment. We applied a fractionated treatment approach, progressively reaching standard doses, to decrease the risk of early death and ensure a successful management.File | Dimensione | Formato | |
---|---|---|---|
Mariani_Arrhythmias_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
691.79 kB
Formato
Adobe PDF
|
691.79 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.